Editorial: Advances in diagnostics and management of adrenal tumors
- PMID: 39950027
- PMCID: PMC11821480
- DOI: 10.3389/fendo.2025.1543773
Editorial: Advances in diagnostics and management of adrenal tumors
Keywords: Cushing syndrome; adrenal tumors; adrenocortical carcinoma; biomarkers; paraganglioma; pheochromocytoma; primary aldosteronism.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The handling editor HF declared a past co-authorship with the author PG.
Comment on
- Editorial on the Research Topic Advances in diagnostics and management of adrenal tumors
References
-
- Honma KI, Nakayama Y, Tamaki A, Uehara M, Teruya T, Yabiku T, et al. . Impact of the transition from radioimmunoassay (RIA) to chemiluminescent enzyme immunoassay (CLEIA) for the measurement of plasma aldosterone concentration (PAC) on the diagnosis of primary aldosteronism (PA) via retrospective analyses in Okinawa. Japan. Endocr J. (2024) 71:895–906. doi: 10.1507/endocrj.EJ24-0227 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources